Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: structure-activity relationships and selective binding patterns.

The substituted thieno[2,3-d]pyrimidine 3 (Org 41841), a partial agonist for the luteinizing hormone/choriogonadotropin receptor (LHCGR) and the closely related thyroid-stimulating hormone receptor (TSHR), was fundamentally altered, and the resulting analogues were analyzed for their potencies, efficacies, and specificities at LHCGR and TSHR. Chemical modification of the parent compound combined with prior mutagenesis of TSHR provided compelling experimental evidence in support of computational models of 3 binding to TSHR and LHCGR within their transmembrane cores. Biochemical analysis of a specific modification to the chemical structure of 3 provides additional evidence of a H-bond between the ligand and a glutamate residue in transmembrane helix 3, which is conserved in both receptors. Several key interactions were surveyed to determine their respective biochemical roles in terms of both van der Waals dimensions and hydrogen bond capacity and the respective relationship to biological activity.

[1]  H. Krishnamurthy,et al.  Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Structure-Function Relationships , 2002 .

[2]  C. Timmers,et al.  The First Orally Active Low Molecular Weight Agonists for the LH Receptor: Thienopyr(im)idines with Therapeutic Potential for Ovulation Induction , 2002, Chembiochem : a European journal of chemical biology.

[3]  T. Guo.  Small molecule agonists and antagonists for the LH and FSH receptors , 2005 .

[4]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[5]  C. Kappe.  Recent Advances in the Biginelli Dihydropyrimidine Synthesis. New Tricks from an Old Dog , 2001 .

[6]  Ruben Abagyan,et al.  ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..

[7]  C. Timmers,et al.  Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor. , 2005, Journal of medicinal chemistry.

[8]  M. Parmentier,et al.  Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. , 1989, Biochemical and biophysical research communications.

[9]  R. Paschke,et al.  Identification of a Novel Epitope in the Thyroid-stimulating Hormone Receptor Ectodomain Acting as Intramolecular Signaling Interface*[boxs] , 2004, Journal of Biological Chemistry.

[10]  K. Jacobson,et al.  Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. , 2004, Journal of medicinal chemistry.

[11]  M. Quon,et al.  Hormone Signaling , 2002, Endocrine Updates.

[12]  R. Paschke,et al.  Role of the third intracellular loop for the activation of gonadotropin receptors. , 1999, Molecular endocrinology.

[13]  Adam J Pawson,et al.  Gonadotropin-releasing hormone receptors. , 2004, Endocrine reviews.

[14]  C. Holmes,et al.  Agonists of the follicle stimulating hormone receptor from an encoded thiazolidinone library. , 2004, Journal of combinatorial chemistry.

[15]  R. Paschke,et al.  A Low Molecular Weight Agonist Signals by Binding to the Transmembrane Domain of Thyroid-stimulating Hormone Receptor (TSHR) and Luteinizing Hormone/Chorionic Gonadotropin Receptor (LHCGR)* , 2006, Journal of Biological Chemistry.